Loading company…
Tianzhu Ruichang develops aortic stent graft systems for treating aortic arch conditions.
Established in 2016 and based in Beijing, China, Tianzhu Ruichang develops aortic stent graft systems. Its three-branch thoracic aorta stent graft system is designed for aortic dissection involving the aortic arch and enables endovascular repair. The company plans to advance clinical trials of a universal three-branch integrated system.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in